FDA to Establish New Cancer Office and Program

July 26, 2004 FDA to Establish New Cancer Office and Program The Food and Drug Administration (FDA) on July 16, 2004, announced plans to make significant changes to its organizational structure to provide for a more consistent approach to the review process for drugs and most therapeutic biologics used to diagnose, treat, and prevent cancer. "This new structure highlights FDA's on-going commitment to finding new and better ways to get safe and effective treatments to cancer patients," said Lester Crawford, acting FDA commissioner. "FDA has worked closely with the cancer community to plan these changes, which have the . . .